Novartis Ag NVS
NYSE NVS
$163.71 +1.16 (+0.71%)
At close: Nov 9, 2026 · 4:00 PM EST

Novartis Ag (NVS) Short-Term Debt repayments (2024)

Updated

Novartis Ag's Short-Term Debt repayments was $578 million in Q4 2024.

Analysis

Novartis Ag (NVS) Short-Term Debt repayments (2024) Analysis & Trends

For FY2024, Short-Term Debt repayments at Novartis Ag came in at $289 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Repayment (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 6.63 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn -
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 139.96 Bn 111.95 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 578.00 Mn
Sep 30, 2024 -289.00 Mn
API Access

Novartis Ag Short-Term Debt repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-repayments&ticker=NVS&period=max&api_key=YOUR_API_KEY